A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy

Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study

NCT07163611 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted

NCT03832114 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

NCT07231679 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

NCT05136456 ·Status: UNKNOWN ·Phase: PHASE2

A Crossover Pilot Study of the Effect of Amiloride on Proteinuria

NCT02522650 ·Status: UNKNOWN ·Phase: PHASE4

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

NCT07289763 ·Status: RECRUITING ·Phase: PHASE2

Obinutuzumab in Primary MN

NCT05050214 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function

NCT01367509 ·Status: COMPLETED ·Phase: PHASE1

Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal Impairment

NCT00445302 ·Status: COMPLETED ·Phase: PHASE1

Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities

NCT06794996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

NCT07204275 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

NCT07157787 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment

NCT05865171 ·Status: COMPLETED ·Phase: PHASE1

CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

NCT03998163 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis

NCT03612856 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

NCT07315360 ·Status: RECRUITING ·Phase: PHASE1

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

NCT05707377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

NCT04859439 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants

NCT05363215 ·Status: COMPLETED ·Phase: PHASE1

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

NCT01958970 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Outcome Analysis of Primary Membranous Nephropathy

NCT06242327 ·Status: RECRUITING

Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

NCT01508468 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function

NCT05404542 ·Status: COMPLETED ·Phase: PHASE1

A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT05521191 ·Status: COMPLETED ·Phase: PHASE1

A Study to See How Safe and Tolerable Different Doses of REGN13335 Are When Administered Intravenously (IV) or Subcutaneously (SC) to Healthy Adult Participants

NCT06137482 ·Status: COMPLETED ·Phase: PHASE1